Elevated cholesterol reduces acetylsalicylic acid-mediated platelet acetylation

Biochimica et Biophysica Acta - General Subjects

Volumn 1770, Issue 12, 2007, Pages 1651-1659

  Boncler, Magdalena ^a   Gresner, Peter ^a   Nocun, Marek ^a,b   Rywaniak, Joanna ^a   Dolnik, Martin ^c   Rysz, Jacek ^a   Wilk, Radoslaw ^a   Czyz, Malgorzata ^a   Markuszewski, Leszek ^a   Banach, Maciej ^a   Watala, Cezary ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b NOFER INSTITUTE OF OCCUPATIONAL MEDICINE   (Poland)

^c Physics and Informatics   (Slovakia)

Author keywords

Acetylsalicylic acid; Aspirin resistance; Cholesterol; Platelet aggregation; Platelet protein acetylation

Indexed keywords

ACETYLSALICYLIC ACID; CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; THROMBOXANE;

ACETYLATION; ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIFFUSION; DRUG INHIBITION; FEMALE; HUMAN; HUMAN EXPERIMENT; HYPERCHOLESTEROLEMIA; IN VITRO STUDY; MALE; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION;

ACETYLATION; ASPIRIN; BLOOD PLATELETS; CHOLESTEROL; HUMANS; LIPID BILAYERS; PLATELET AGGREGATION; THROMBOXANES;

EID: 35448979443     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2007.09.002     Document Type: Article

References (31)

1. Hankey G.J., and Eikelboom J.W. Aspirin resistance. Lancet 367 (2006) 606-617
2. Undas A., Brummel-Ziedins K.E., and Mann K.G. Antithrombotic properties of aspirin and resistance to aspirin: beyond strictly antiplatelet actions. Blood 109 (2007) 2285-2292
3. Davi G., Alessandrini P., Mezzetti A., Minotti G., Bucciarelli T., Costantini F., Cipollone F., Bon G.B., Ciabattoni G., and Patrono C. In vivo formation of 8-Epi-prostaglandin F2 alpha is increased in hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol. 17 (1997) 3230-3235
4. Szczeklik A., Musial J., Undas A., Swadzba J., Gora P.F., Piwowarska W., and Duplaga M. Inhibition of thrombin generation by aspirin is blunted in hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol. 16 (1996) 948-954
5. Watala C., and Gwozdzinski K. Effect of aspirin on conformation and dynamics of membrane proteins in platelets and erythrocytes. Biochem. Pharmacol. 45 (1993) 1343-1349
6. Watala C., Golanski J., Pluta J., Boncler M., Rozalski M., Wieclawska B., Kropiwnicka A., and Drzewoski J. Reduced sensitivity of platelets from type 2 diabetic patients to acetylsalicylic acid (Aspirin)-its relation to metabolic control. Thromb. Res. 113 (2004) 101-113
7. Velez M., Lillo M.P., Acuna A.U., and Gonzalez-Rodriguez J. Cholesterol effect on the physical state of lipid multibilayers from the platelet plasma membrane by time-resolved fluorescence. Biochim. Biophys. Acta 1235 (1995) 343-350
8. Kwiatkowska K., and Sobota A. The clustered Fcgamma receptor II is recruited to Lyn-containing membrane domains and undergoes phosphorylation in a cholesterol-dependent manner. Eur. J. Immunol. 31 (2001) 989-998
9. Shattil S.J., Anaya-Galindo R., Bennett J., Colman R.W., and Cooper R.A. Platelet hypersensitivity induced by cholesterol incorporation. J. Clin. Invest. 55 (1975) 636-643
10. Grgurevich S., Krishnan R., White M.M., and Jennings L.K. Role of in vitro cholesterol depletion in mediating human platelet aggregation. J. Thromb. Haemost. 1 (2003) 576-586
11. Tomizuka T., Yamamoto K., Hirai A., Tamura Y., and Yoshida S. Hypersensitivity to thromboxane A2 in cholesterol-rich human platelets. Thromb. Haemost. 64 (1990) 594-599
12. Heider J.G., and Boyett R.L. The picomole determination of free and total cholesterol in cells in culture. J. Lipid Res 19 (1978) 514-518
13. Boncler M., Luzak B., Rozalski M., Golanski J., Rychlik B., and Watala C. Acetylsalicylic acid is compounding to antiplatelet effect of C-reactive protein. Thromb. Res. 119 (2006) 209-216
14. Nocun M., Golanski J., Lapshina E., Zavodnik L., Dobaczewski M., Kazmierczak P., Markuszewski L., Zavodnik I., and Watala C. Usefulness of whole blood aggregometry and its comparison with thromboxane generation assay in monitoring acetylsalicylic acid effectiveness-a multiparametric study in rats. Clin. Chem. Lab Med. 44 (2006) 653-662
15. Watala C., Ulicna O., Golanski J., Nocun M., Waczulikova I., Markuszewski L., and Drzewoski J. High glucose contributes to aspirin insensitivity in streptozotocin-diabetic rats: a multiparametric aggregation study. Blood Coagul. Fibrinolysis 17 (2006) 113-124
16. Pike L.J., and Miller J.M. Cholesterol depletion delocalizes phosphatidylinositol bisphosphate and inhibits hormone-stimulated phosphatidylinositol turnover. J. Biol. Chem. 273 (1998) 22298-22304
17. Drzewiecka A., Kwiatkowska K., and Sobota A. The role of cholesterol and sphigomyelin in tyrosine phosphorylation of proteins and capping of Fcgamma receptor. Acta Biochim. Pol. 46 (1999) 107-116
18. Kates M. Lipid Extraction Procedures. In: Burdon R.H., and van Knippenberg P.H. (Eds). Laboratory Techniques in Biochemistry and Molecular Biology: Techniques of Lipidology (1986), Elsevier Scientific Publishing Co., New York 100-111
19. Watala C., Pluta J., Golanski J., Rozalski M., Czyz M., Trojanowski Z., and Drzewoski J. Increased protein glycation in diabetes mellitus is associated with decreased aspirin-mediated protein acetylation and reduced sensitivity of blood platelets to aspirin. J. Mol. Med. 83 (2005) 148-158
20. Mueller P., Rudin D.O., Tien H.T., and Wescott W.C. Reconstitution of cell membrane structure in vitro and its transformation into an excitable system. Nature 194 (1962) 979-980
21. Tandon N.N., Harmon J.T., and Jamieson G.A. Influence of Membrane Fluidity on Platelet Activation in Cholesterol-Modified and Hypercholesterolemic Platelets. In: Aloia R.C., Curtain C.C., and Gordon L.M. (Eds). Lipid Domains and the Relationship to Membrane Function (1988), Alan R. Liss Inc., New York 83-99
22. Howard P.A. Aspirin resistance. Ann. Pharmacother. 36 (2002) 1620-1624
23. Friend M., Vucenik I., and Miller M. Research pointers: platelet responsiveness to aspirin in patients with hyperlipidaemia. BMJ 326 (2003) 82-83
24. Szczeklik A. Thrombin generation in myocardial infarction and hypercholesterolemia: effects of aspirin. Thromb. Haemost. 74 (1995) 77-80
25. Szczeklik A., Musial J., Undas A., and Sanak M. Aspirin resistance. J. Thromb. Haemost. 3 (2005) 1655-1662
26. Mori T.A., Vandongen R., Douglas A.J., McCulloch R.K., and Burke V. Differential effect of aspirin on platelet aggregation in IDDM. Diabetes 41 (1992) 261-266
27. Saniabadi A.R., Umemura K., Shimoyama M., Adachi M., Nakano M., and Nakashima M. Aggregation of human blood platelets by remnant like lipoprotein particles of plasma chylomicrons and very low density lipoproteins. Thromb. Haemost. 77 (1997) 996-1001
28. Shinitzky M. Membrane Fluidity and Cellular Functions. In: Shinitzky M. (Ed). Physiology of Membrane Fluidity vol. 1 (1984), Plenum Press, New York 1-51
29. Boesze-Battaglia K., and Schimmel R. Cell membrane lipid composition and distribution: implications for cell function and lessons learned from photoreceptors and platelets. J. Exp. Biol. 200 (1997) 2927-2936
30. Jungner I., Sniderman A.D., Furberg C., Aastveit A.H., Holme I., and Walldius G. Does low-density lipoprotein size add to atherogenic particle number in predicting the risk of fatal myocardial infarction?. Am. J. Cardiol. 97 (2006) 943-946
31. Berneis K., Jeanneret C., Muser J., Felix B., and Miserez A.R. Low-density lipoprotein size and subclasses are markers of clinically apparent and non-apparent atherosclerosis in type 2 diabetes. Metabolism 54 (2005) 227-234